Advertisement

Topics

Timwell Forms $20 Million JV with ReWalk for China Sales of Exoskeleton

00:04 EDT 15 Mar 2018 | ChinaBio Today

Timwell, a Hong Kong medical device company, will invest $20 million in ReWalk Robotics, an Israeli company that has developed a soft-suit exoskeleton to help patients walk after a stroke. Timwell, ReWalk and RealCan Ambrum Investment will form a China JV to develop, produce and market the Restore exoskeleton in greater China. After the tranched investment is complete, Timwell will own 16 million shares of ReWalk, a 35% share of the company. More details....

Stock Symbol: (NSDQ:RWLK)

Share this with colleagues:

Original Article: Timwell Forms $20 Million JV with ReWalk for China Sales of Exoskeleton

NEXT ARTICLE

More From BioPortfolio on "Timwell Forms $20 Million JV with ReWalk for China Sales of Exoskeleton"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...